Distinguishable transformation-defective phenotypes among temperature-sensitive mutants of Rous sarcoma virus.
Eight transformation-defective, temperature-sensitive (ts) mutants of the Prague strain of Rous sarcoma virus, subgroup A, have been isolated after mutagenesis with 5-bromodeoxyuridine followed by selection on the basis of focus tests. Five of these mutants, ts GI201, GI202, GI203, GI204, and GI205, exhibit properties like most previously reported isolates in that they show a temperature-sensitive response to each of a variety of transformation-specific parameters tested. Interestingly, GI201, in addition to the temperature-sensitive defect, carries a lesion that was observed as a nonconditional loss of expression of plasminogen activator protease. Three mutants, ts GI251, GI252, and GI253 have been disignated partial transformation-defective (PTD) mutants since they behave as ts mutants according to some tests for transformation and as wild type according to others. These three mutants fail to form foci at the nonpermissive temperature (41 degrees C) and art nontumorigenic in 3-week-old chickens (body temperature, 42 degrees C). The agglutinability by concanavalin A of cells infected with these mutants shows a definite  temperature sensitivity, as do the rate of 2-deoxyglucose uptake and the disappearance of the 250, 000-dalton normal cell glycoprotein (large, external, transformation sensitive [LETS]). Although the PTD mutant-infected cells, unlike cells infected with other transformation mutants, exhibit a cell-bound plasminogen activator protease at the nonpermissive temperature, this activator is not detectable as a free protease in the medium, as it is with wild-type, virus-infected cells. The PTD mutants behave like the wild-type parent in their ability to induce transformed growth properties in the infected cells, i.e., growth beyond normal cell saturation density with or without serum-supplemented medium and growth leading to colony formation in soft-agar- or methyl cellulose-containing suspension media.
D000371:Agglutination; D001358:Avian Sarcoma Viruses / Q000254:growth & development*; D001973:Bromodeoxyuridine; D002471:Cell Transformation, Neoplastic; D003208:Concanavalin A / Q000494:pharmacology; D046508:Culture Techniques; D003847:Deoxyglucose / Q000378:metabolism; D006023:Glycoproteins / Q000096:biosynthesis; D009153:Mutagens; D009154:Mutation; D010641:Phenotype; D010960:Plasminogen Activators / Q000378:metabolism; D013696:Temperature
D006023:Glycoproteins; D009153:Mutagens; D003208:Concanavalin A; D003847:Deoxyglucose; D010960:Plasminogen Activators; D001973:Bromodeoxyuridine